Propranolol versus Other Selected Drugs in the Treatment of Various Types of Anxiety or Stress, with Particular Reference to Stage Fright and Post-Traumatic Stress Disorder
Open accessThe DOI matches its Crossref record; 194 of the 195 references it cites were found in a registry or an index.
Abstract
Propranolol, a non-cardioselective β1,2 blocker, is most commonly recognised for its application in the therapy of various cardiovascular conditions, such as hypertension, coronary artery disease, and tachyarrhythmias. However, due to its ability to cross the blood–brain barrier and affinity towards multiple macromolecules, not only adrenoreceptors, it has also found application in other fields. For example, it is one of the very few medications successfully applied in the treatment of stage fright. This review focuses on the application of propranolol in the treatment of various types of anxiety and stress, with particular reference to stage fright and post-traumatic stress disorder (PTSD). Both mechanisms of action as well as comparison with other therapies are presented. As those indications for propranolol are, in most countries, considered off-label, this review aims to gather information that can be useful while making a decision about the choice of propranolol as a drug in the treatment of those mental conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The Trier Social Stress Test (TSST) is regarded as the gold standard in simulating a stressful social situation”
From Efficacy and safety of an alpha 7-nicotinic acetylcholine receptor agonist, VQW-765, in subjects with performance anxiety: randomised, double-blind, placebo-controlled trial (2025) · cites this paper as [10]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Rayyan-a web and mobile app for systematic reviews.
Ouzzani, M., Hammady, H., Fedorowicz, Z., & Elmagarmid, A. (2016) · Systematic Reviews · doi:10.1186/s13643-016-0384-4 · Cited by 26,092
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · Systematic Reviews · doi:10.1186/s13643-021-01626-4 · Cited by 13,874 · cited 1×
“The present review was performed according to the Preferred Reporting Items for Systematic Reviews (PRISMA) statement (Figure 3) [193], and it was registered in the Open Science Framework (OSF) (registration: https://doi.”
MethodThe PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · International Journal of Surgery · doi:10.1016/j.ijsu.2021.105906 · Cited by 11,748
Posttraumatic Stress Disorder in the National Comorbidity Survey
Kessler, R. C. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240066012 · Cited by 10,379 · cited 2×
“However, at least a third of those who initially develop PTSD continue to face symptoms for three years or longer [21].”
BackgroundThe PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J., Bossuyt, P., Boutron, I., Hoffmann, T., mulrow, C., Shamseer, L., Tetzlaff, J., Akl, E., Brennan, S. E., et al. (2020) · doi:10.31222/osf.io/v7gm2_v1 · Cited by 8,090
Fear memories require protein synthesis in the amygdala for reconsolidation after retrieval
Nader, K., Schafe, G. E., & Le Doux, J. E. (2000) · Nature · doi:10.1038/35021052 · Cited by 2,706 · cited 2×
“Fear memory reconsolidation is the process by which reactivation by exposure to the conditioned stimulus (CS) or an unconditioned stimulus (US) makes memory traces labile, thereby triggering transient protein destabilisation that can be modified by pharmacological and behavioural interventions for several hours after…”
BackgroundTolin, D. F., & Foa, E. B. (2006) · Psychological Bulletin · doi:10.1037/0033-2909.132.6.959 · Cited by 2,197 · cited 1×
“Females are more than twice as likely as males to develop PTSD following a traumatic event [32].”
BackgroundThe global burden of mental disorders: An update from the WHO World Mental Health (WMH) surveys
Kessler, R. C., Aguilar-Gaxiola, S., Alonso, J., Chatterji, S., Lee, S., Ormel, J., Üstün, T. B., & Wang, P. S. (2009) · Epidemiologia e Psichiatria Sociale · doi:10.1017/s1121189x00001421 · Cited by 1,895 · cited 1×
“The majority of mental health disorders are anxiety-related [84], and they have significant psychological, social, and financial implications [85].”
BackgroundBiological studies of post-traumatic stress disorder
Pitman, R. K., Rasmusson, A. M., Koenen, K. C., Shin, L. M., Orr, S. P., Gilbertson, M. W., Milad, M. R., & Liberzon, I. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3339 · Cited by 1,529
Research works printed but not linked: 2
- Barlow D.H. Anxiety and Its Disorders: The Nature and Treatment of Anxiety and Panic 2nd ed. Guilford Press New York, NY, USA 2002
- O’Reagan J.B. The treatment of acute postpartum psychosis Can. Med. Assoc. J. 1981 125 1083 PMC1862669 7326636
Cited by
Beta-blockers in cardiac arrhythmias–Clinical pharmacologist’s point of view
Wołowiec, Ł., Grześk, G., Osiak, J., Wijata, A., Mędlewska, M., Gaborek, P., Banach, J., Wołowiec, A., & Głowacka, M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1043714 · Cited by 58
“Moreover, another meta-analysis also showed a lack of evidence of satisfactory quality to determine, whether or not to use propranolol in the treatment of stage fright (Szeleszczuk and Frączkowski, 2022).”
BackgroundBeta-blockers for the treatment of anxiety disorders: A systematic review and meta-analysis
Archer, C., Wiles, N., Kessler, D. A., Turner, K. M., & Caldwell, D. M. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.09.068 · Cited by 40
Network Meta-analysis of Different Treatments for Vestibular Migraine
Chen, J.-J., Zeng, B., Su, K., Wu, Y., Tu, Y., Stubbs, B., Chen, T., Zeng, B., Chen, Y., Hsu, C., et al. (2023) · CNS Drugs · doi:10.1007/s40263-023-01037-0 · Cited by 28
“Propranolol, which can cross the blood–brain barrier, acts not only on the β-adrenergic receptor but also weakly on certain serotonin receptors, such as 5-HT1A, 5-HT1B, and 5-HT2B [59], thus exerting anxiolytic effects [59].”
BackgroundDepression and anxiety management in cirrhosis
Zimbrean, P. C., & Jakab, S. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000600 · Cited by 24
Li, H., Cheng, H., Ding, K., Zhang, Y., Gao, F., Zhu, G., & Zhang, Z. (2024) · European Journal of Neuroscience · doi:10.1111/ejn.16445 · Cited by 14
“Propranolol acts on brain areas critical for learning and memory, including the hippocampus, PFC, and dorsal dentate gyrus (Szeleszczuk & Fraczkowski, 2022).”
Post-Traumatic Stress Disorder (PTSD) in Trauma Patients
Radow, B. S., Anderson, N., & Richmond, B. K. (2024) · The American Surgeon · doi:10.1177/00031348241290610 · Cited by 16
Considerations in the Treatment of Depression and Anxiety in Women with PCOS
Alur-Gupta, S., & Dokras, A. (2023) · Seminars in Reproductive Medicine · doi:10.1055/s-0043-1777720 · Cited by 12
GPs’ views of prescribing beta- blockers for people with anxiety disorders: a qualitative study
Archer, C., Kessler, D. S., Wiles, N., Chew-Graham, C. A., & Turner, K. M. (2024) · British Journal of General Practice · doi:10.3399/bjgp.2024.0091 · Cited by 9
“Existing research suggests that beta-blockers are widely used for situational anxiety, 30,31 and GPs in our study described this as one of the situations where they might prescribe beta-blockers.”
BackgroundHyjek, K., Kurowski, G., Dymek, K., Boguszewska‐Czubara, A., Budzyńska, B., Wronikowska‐Denysiuk, O., Gajda, A., Piskorz, W., Śliwa, P., Szumera, M., et al. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.147655 · Cited by 7
Propranolol Hydrochloride Psychiatric Effectiveness and Oxidative Stress: An Update
Serreau, R., Amirouche, A., Benyamina, A., & Berteina‐Raboin, S. (2024) · Oxygen · doi:10.3390/oxygen4020009 · Cited by 10
“For the time being, these extra-cardiological indications remain in the research domain and have not received marketing authorization [5].”
BackgroundKhoury, R. D., Minhoto, G. B., de Barros, P. P., Junqueira, J. C., Gagliardi, C. F., do Prado, R. F., & Valera, M. C. (2024) · International Endodontic Journal · doi:10.1111/iej.14118 · Cited by 6
Bianjiang, Z., Jianchun, Z., Xiaoyu, S., & Yang, J. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06620-x · Cited by 14
“…worldwide have proposed a range of therapeutic approaches, encompassing both conventional pharmacological treatments and various forms of complementary and alternative medicine (CAM) therapies. interventions commonly involve the administration of [31], anxiolytics [32], or hypnotics [33].”
He, Y., Polymeropoulos, C. M., Mohrman, M. A., Truslow, S. O., Xiao, C., Wu, Y., Birznieks, G., & Polymeropoulos, M. H. (2025) · The British Journal of Psychiatry · doi:10.1192/bjp.2025.84 · Cited by 5
“5,6 Selective serotonin reuptake inhibitors have been approved for the treatment of anxiety disorders, including SAD, 7,8 but cannot be used for on-demand treatment due to their slow onset of action.”
Isoardi, K., Chiew, A. L., Do, C., Humphreys, M., Mustafa, A., Roberts, M. S., & Isbister, G. K. (2024) · Clinical Toxicology · doi:10.1080/15563650.2024.2435397 · Cited by 5
“Propranolol is also used in the management of migraine, essential tremor, anxiety, and post-traumatic stress disorder [5].”
Martínez, R. M., Chou, S.-H., Fan, Y., Chen, Y.-C., Goh, K. K., & Chen, C. (2024) · Scientific Reports · doi:10.1038/s41598-024-51345-8 · Cited by 9
“…studies using the noradrenergic beta-adrenoceptor antagonist propranolol –originally developed to treat heart and circulatory-related conditions 21,22 – have observed the drug’s ability to influence moral decision-making; as its administration reduced participants’ utilitarian responses in a…”
MethodResultLakhawat, S. S., Mech, P., Kumar, A., Malik, N., Kumar, V., Sharma, V., Bhatti, J. S., Jaswal, S. K., Kumar, S., & Sharma, P. K. (2024) · Metabolic Brain Disease · doi:10.1007/s11011-024-01453-1 · Cited by 7
The Therapeutic Potential of Propranolol and Other Beta-Blockers in Hyperthyroidism
Szybiak, W., Miedziaszczyk, M., Szałek, E., & Łącka, K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178322 · Cited by 7
“Moreover, propranolol is a weak indirect α 1-adrenoceptor agonist [69,70], and it has been proven that it may act as a weak antagonist of certain serotonin receptors, 5-HT1A, 5-HT1B, and 5-HT2B, thus presenting an anxiolytic effect [71].”
Zhu, M., Zheng, B., Zhang, Y. S., Sun, R., Xu, X., Tian, R., Li, X., Wang, G., Wang, X., & Liu, Z. (2024) · The FASEB Journal · doi:10.1096/fj.202401027r · Cited by 2
Nature-based mind–body intervention for test anxiety in adolescents: a feasibility study
Zeng, X., Zhang, Y., Chu, Z., & Chen, T. (2025) · Frontiers in Psychology · doi:10.3389/fpsyg.2025.1550353 · Cited by 6
“Pharmacological treatments, such as anti-anxiety and antidepressant medications, provide rapid symptom relief but carry potential side effects and dependency risks and fail to address the underlying psychological causes of anxiety (Szeleszczuk and Frączkowski, 2022).”
Noradrenergic and Dopaminergic modulation of meta-cognition and meta-control
Ershadmanesh, S., Rajabi, S., Rostami, R., Moran, R., & Dayan, P. (2025) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1012675 · Cited by 4
“Propranolol: Reflecting the very broad impact of the noradrenergic system, this drug is indicated for various anxiety and stress-related conditions, including stage fright, post-traumatic stress disorder (PTSD), arachnophobia, and autism spectrum disorder [e.g., 44–48].”
Szeleszczuk, Ł., Bethanis, K., Christoforides, E., & Pisklak, D. M. (2024) · CrystEngComm · doi:10.1039/d4ce01105h · Cited by 3
Self-citationIntroduction to neurobiology and pharmacology of stress
Abbasi-Maleki, S., Nakhaei, B., Mehr, S. R., & Moradikor, N. (2025) · Progress in brain research · doi:10.1016/bs.pbr.2025.01.006 · Cited by 3
Taha, H. A., Awamleh, S., Tayyeb, A. A., Samhouri, S., Abbasi, Y., Alwaked, L., Jaber, A. E., Massad, R., & Alkhaldi, S. M. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1586068 · Cited by 5
Propranolol Use Among Healthcare Students in Saudi Arabia
Aljahdali, S. H., Badr, R., Alotaibi, M. S., Alhelali, S., Abdullatif, G., Alshanberi, A. M., Fairaq, A., Elashmony, S. M., Falemban, A. H., Alsanosi, S., et al. (2023) · Cureus · doi:10.7759/cureus.48606 · Cited by 3
“The highest reported dose was 40 mg, which was close to the highest reported dose in our results [28].”
ResultCardiomyopathies and Psychiatric Disorders: An Overview and General Clinical Recommendations
Stanca, A., Carella, M. C., Basile, P., Forleo, C., Ciccone, M. M., & Guaricci, A. I. (2024) · Cardiology in Review · doi:10.1097/crd.0000000000000693 · Cited by 3
Potential use of propranolol in autism spectrum disorder: A narrative review
Soriano, L. F., Huguet, A. I., Tauler, J. M. A., Cañellas, J. M., Gost, C. V. S., Motilla, S. J., Rodríguez-Quiroga, A., Quintero, M., & Quintero, J. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251399567 · Cited by 2
“In social and performance anxiety, a subtype of social phobia characterized by sympathetic overactivation, propranolol effectively reduces tachycardia, tremor, and sweating by antagonizing peripheral β 1/ β 2 receptors (Baron and O’Donnell, 2025; Szeleszczuk and Frączkowski, 2022).”
Niu, J., Wei, X., Li, H., Xia, R., Wang, J., Zhang, J., Yang, S., Zhu, G., & Chen, L. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.178961 · Cited by 1
Therapeutic potential of propranolol in central nervous system disorders
Zhao, J.-N., Zhang, H., Jing-yu, Y., Yin, Y., & Zhang, L. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1752025 · Cited by 2
“Many mental disorders are comorbid with anxiety (41), and they have signi fi cant psychological, social, and economic impacts.”
Saad, S. E. A., Aburawi, S. M., Rahoumh, A. A., Rahoumh, A. A., & Abdraheem, A. (2022) · Libyan Journal of Medical Research · doi:10.54361/ljmr.16210
Analysis of Common Genetic Variation of Anxiety Disorders in Essential Tremor
Yan, Y., Cao, L., Gu, L., Xu, C., Lu, J., Lv, D., Tian, J., Yin, X., Pu, J., Zhang, B., et al. (2025) · Journal of Molecular Neuroscience · doi:10.1007/s12031-024-02226-2
“Propranolol, a first-line treatment for ET, is also widely recognized for its application in anxiety disorders (Ferreira et al. 2019; Szeleszczuk and Frączkowski 2022).”
Melefa, T. D., Andong, F. A., Hinmikaiye, F. F., Ozota, E. E., Nwoko, M.-C., Ubah, V. C. S., Ugwu, G. N., & Nwani, C. D. (2025) · Journal of Aquatic Animal Health · doi:10.1093/jahafs/vsaf004 · Cited by 1
ALTERNATIVAS FARMACOLÓGICAS PARA O TRATAMENTO DE TRANSTORNOS DE ANSIEDADE: UMA REVISÃO DA LITERATURA
Lopes, R. M. L., Galvão, J. G. F. M., Marques, A. E. F., & Pereira, L. R. D. A. B. (2025) · Revista interdisciplinar em saúde · doi:10.35621/23587490.v12.n1.p1507-1530 · Cited by 1
Rouhzendeh, S., Mousavi, Z., Mashayekh‐Amiri, S., Shaseb, E., Mirmolaei, S. T., & Mirghafourvand, M. (2025) · Journal of Pharmaceutical Health Care and Sciences · doi:10.1186/s40780-025-00466-x
“Consequently, the quality of evidence for the effectiveness of propranolol is currently insufficient to support its routine use in treating fear and anxiety disorders [20].”
Quarto, F. H. A., de Almeida, J. M., Cunha, P. A. R., & Martins, T. A. (2025) · STUDIES IN HEALTH SCIENCES · doi:10.54022/shsv6n3-019
Ahari, N. J., & Fonzo, G. A. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1665770 · Cited by 1
Šimunovič, N. (2025) · Frontiers in Psychology · doi:10.3389/fpsyg.2025.1706198
Regulatory considerations for new drugs and devices
Klosowiak, J. L., & Galiano, R. D. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-91168-9.00014-4
Wen, S., Huang, T., Yuan, Y., Li, Y., Yuan, S., & Zheng, W. (2026) · Journal of Visualized Experiments · doi:10.3791/69859
Golden window of intervention in PTSD: a synthesis of preclinical evidence
Kannan, D., Arun, M., Ravi, S., & Chakraborty, P. (2026) · Psychopharmacology · doi:10.1007/s00213-026-07088-7
Psychological Scars and Physical Consequences: Linking PTSD to Cardiovascular Health
Corker, A., Oh, G., & DeLeon‐Pennell, K. Y. (2026) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-026-10783-7
“By dampening sympathetic dominance, propranolol may enhance PNS activity and HRV, which is linked to better emotional regulation and stress resilience [138, 139].”
Leistungssteigernde Mittel im Alltag und im Arbeitsleben
Milin, S., Ebel, F. A., & Schäfer, I. (2026) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-026-04254-2
“Ne-benwirkungenwieBradykardie,Hypoto-nie und Müdigkeit machen den Einsatz außerhalb klarer medizinischer Indikationen kritisch [51].”
How do beta blocker heart drugs actually work for anxiety?
Wheate, N., & Lee, J. (2026) · doi:10.64628/aa.fpvf3jgjq
Mela, M., Hinz, T., Chicoine, C., Zidenberg, A. M., Lim, H. J., Madampage, C. A., & Menzies, R. (2026) · The European Journal of Psychiatry · doi:10.1016/j.ejpsy.2026.100363
Alzoubi, M., Safadi, W. A., Sorour, S., Ammori, R., Ahmad, A., Dawud, Y., Shalash, F., Mohammad, M., & MOHAMMAD, M. (2026) · Healthcare · doi:10.3390/healthcare14152257
“This pattern reflects situational or performance-based use rather than therapeutic use and may contribute to increased psychological reliance on the medication [40].”
Costa, A., Davidson, S., Rakhamimova, E., Bartula, B., Geralemou, S., Wang, W., & Bergese, S. D. (2026) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl48402
Arora, S., Mehta, S., & Arun, P. (2026) · Journal of Indian Association for Child and Adolescent Mental Health · doi:10.1177/09731342261489080
Metadata
- Authors
- Szeleszczuk, Ł., & Frączkowski, D.
- Affiliations
- Medical University of Warsaw (PL)
- Corresponding author
- Szeleszczuk, Łukasz
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-09-03
- Volume
- 23
- Issue
- 17
- Pages
- 10099
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC9456064
- OpenAlex
- W4294733063
- Cited by
- 46
- References
- 195
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 13 · 2023: 5 · 2022: 1
- FWCI
- 1.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Keywords
- propranolol, stage fright, post-traumatic stress disorder, anxiety, stress, off-label drug use, beta-blockers, adrenergic receptors, blood-brain barrier, mechanism of action, drug comparison
- MeSH terms
- Anxiety, Anxiety Disorders, Humans, Propranolol, Stress Disorders, Post-Traumatic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.


